GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Opsens Inc (TSX:OPS) » Definitions » Return-on-Tangible-Equity

Opsens (TSX:OPS) Return-on-Tangible-Equity : -19.89% (As of Aug. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Opsens Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Opsens's annualized net income for the quarter that ended in Aug. 2023 was C$-6.52 Mil. Opsens's average shareholder tangible equity for the quarter that ended in Aug. 2023 was C$32.80 Mil. Therefore, Opsens's annualized Return-on-Tangible-Equity for the quarter that ended in Aug. 2023 was -19.89%.

The historical rank and industry rank for Opsens's Return-on-Tangible-Equity or its related term are showing as below:

TSX:OPS' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -154.64   Med: -34.75   Max: -4.23
Current: -37.73

During the past 13 years, Opsens's highest Return-on-Tangible-Equity was -4.23%. The lowest was -154.64%. And the median was -34.75%.

TSX:OPS's Return-on-Tangible-Equity is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 1.395 vs TSX:OPS: -37.73

Opsens Return-on-Tangible-Equity Historical Data

The historical data trend for Opsens's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Opsens Return-on-Tangible-Equity Chart

Opsens Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.33 -17.55 -4.23 -31.12 -38.38

Opsens Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -47.17 -47.16 -35.94 -47.18 -19.89

Competitive Comparison of Opsens's Return-on-Tangible-Equity

For the Medical Instruments & Supplies subindustry, Opsens's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Opsens's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Opsens's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Opsens's Return-on-Tangible-Equity falls into.



Opsens Return-on-Tangible-Equity Calculation

Opsens's annualized Return-on-Tangible-Equity for the fiscal year that ended in Aug. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Aug. 2023 )  (A: Aug. 2022 )(A: Aug. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Aug. 2023 )  (A: Aug. 2022 )(A: Aug. 2023 )
=-12.402/( (32.473+32.156 )/ 2 )
=-12.402/32.3145
=-38.38 %

Opsens's annualized Return-on-Tangible-Equity for the quarter that ended in Aug. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Aug. 2023 )  (Q: May. 2023 )(Q: Aug. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Aug. 2023 )  (Q: May. 2023 )(Q: Aug. 2023 )
=-6.524/( (33.441+32.156)/ 2 )
=-6.524/32.7985
=-19.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Aug. 2023) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Opsens  (TSX:OPS) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Opsens Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Opsens's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Opsens (TSX:OPS) Business Description

Traded in Other Exchanges
N/A
Address
750, Boulevard du Parc-Technologique, Quebec, QC, CAN, G1P 4S3
OpSens Inc. is engaged in physiological measurements such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and in transcatheter aortic valve replacement (TAVR) in the structural heart market. It operates in two segments that are Medical and Industrial. In Medical segment it supplies an optical-based pressure guidewire (OptoWire), a guidewire used in the TAVR procedure (SavvyWire) and a wide range of miniature optical sensors to measure pressure and temperature to be used in a wide range of applications that can be integrated into other medical devices. Industrial segment includes developing, manufacturing and installing fibre optic sensing solutions for industrial applications. Majority of its revenue is derived from Medical segment.
Executives
Alan Milinazzo Director
Robin Villeneuve Senior Officer
Fiera Capital Corporation (formerly Fiera Sceptre Inc.) 10% Security Holder

Opsens (TSX:OPS) Headlines

No Headlines